The Controlled Substances Ordering System (CSOS) is an electronic commerce initiative overseen by the U.S. Drug Enforcement Administration (DEA) to provide an automated alternative to the current paper-intensive process required for purchasing and distributing Level I and II controlled substances. As a neutral third party, DGI will provide CSOS Auditing services such as delivering certification for software products-with-version in compliance with DEA rules.

CSOS Auditing certification is proof that software offerings can enable purchasers and suppliers to interchange e222 forms in a predictable and secure manner compliant with DEA requirements. In addition, DGI will continue to promote long-term interoperability of CSOS and related systems by working with the software vendors and end-user corporations to combine DEA requirements with recommendations from industry consortia such as the Healthcare Distribution Management Association (HDMA) to promote implementation of CSOS-compliant production systems.

Importance of CSOS Auditing
DEA requires for systems used to process CSOS orders, the system developer or vendor must have an initial independent third party audit of the system.

Results of DGI's initial CSOS audit certification round--June 2005 >>

To register for CSOS auditing >>

Frequently Asked Questions (FAQs) about CSOS >>

Information Week article, "Drug Industry to Shift to Digital Orders" >>

Additional Information

Introduction to CSOS auditing, "Drummond.CSOS Audit Presentation," presented at ASAP conference in January 2005: >>

For more information about CSOS, please visit the DEA website: http://www.deaecom.gov/

For more information about DGI testing, please visit: http://www.drummondgroup.com

FAQs on AS2 and Interoperability may be found at: http://www.drummondgroup.com/html-v2/faq-retail-as2.html

FIPS in a Nutshell >